Bill of Health

APRIL 7, 2022

The proposed compromise would allow for “the use of patented subject matter required for the production and supply of COVID-19 vaccines without the consent of the right holder to the extent necessary to address the COVID-19 pandemic, in accordance with the provisions of Article 31 of the Agreement, as clarified and waived.”

COVID-19 363

COVID-19 COVID-19 Vaccine Licensing Public Health 363

Bill of Health

SEPTEMBER 13, 2022

While the National Institute on Drug Abuse Director characterizes America’s drug overdose mortality as “truly staggering” and the White House calls “the accelerating pace of overdose deaths ‘unacceptable,’” our government refuses to make meaningful changes to reverse course. While the U.S.

Public Health 237

Public Health COVID-19 Governance Health Outcomes 237

SQA

APRIL 30, 2021

Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19 Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19 vaccine exports. The EU continues to be the leading provider of vaccines around the world.

COVID-19 Vaccine 52

COVID-19 Vaccine COVID-19 Compliance Governance 52